Upgrade to SI Premium - Free Trial

Citizens on Allogene (ALLO): 'We View Shares as an Attractive Investment Opportunity'

March 16, 2026 4:47 AM
Citizens analyst Reni Benjamin reiterated a Market Outperform rating and $5.00 price target on Allogene (NASDAQ: ALLO).The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments